Mirvetuximab Antibody
Mirvetuximab is a monoclonal antibody targeting folate receptor alpha (FRα/FOLR1) . Its antibody-drug conjugate, mirvetuximab soravtansine, is utilized in research for targeting FRα-positive cancers, such as ovarian cancer, in both in vitro and in vivo experimental models.
Product Specifications
Product Name Alternative
M9346A, Mirvetuximab, Antifolate
Target
ADC Antibody, Antifolate
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
3.28 mg/mL
Purity
>95% (May vary between batches)
Molecular Weight
145.96 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941231-100 1x 100 µL
Eosinophil Peroxidase (AHE-1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400470-100 1x 100 µL
CD45 / LCA (2B11), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400527-500 1x 500 µL
Nucleolin (364-5), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940201-100 1x 100 µL
CD2 / Lymphocyte Function Antigen 2 (LFA-2) (UMCD2), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680409-100 1x 100 µL
UPK3A (Uroplakin 3A) (Rabbit PAb), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details